Jonathan Slonin insider trades: Pacira BioSciences (PCRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jonathan reports to the SEC
Open-market buys and sales
9 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | PCRX | ↓ Sell10b5-1 | 3,960 | $24.09 | $95K | Direct | Nov 19, 2025 (2d) |
| Jan 6, 2025 | PCRX | ↓ Sell | 879 | $18.40 | $16K | Direct | Jan 6, 2025 (0d) |
| Aug 2, 2024 | PCRX | ↓ Sell | 945 | $20.05 | $19K | Direct | Aug 2, 2024 (0d) |
| Jul 2, 2024 | PCRX | ↓ Sell | 2,836 | $28.25 | $80K | Direct | Jul 3, 2024 (1d) |
| Jun 11, 2024 | PCRX | ↓ Sell10b5-1 | 5,012 | $28.57 | $143K | Direct | Jun 13, 2024 (2d) |
| Jun 7, 2023 | PCRX | ↓ Sell | 961 | $38.42 | $37K | Direct | Jun 7, 2023 (0d) |
| Aug 3, 2022 | PCRX | ↓ Sell | 308 | $55.70 | $17K | Direct | Aug 5, 2022 (2d) |
| Jul 5, 2022 | PCRX | ↓ Sell | 924 | $57.19 | $53K | Direct | Jul 7, 2022 (2d) |
| Jun 6, 2022 | PCRX | ↓ Sell | 362 | $61.37 | $22K | Direct | Jun 8, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PCRX insiders
Open-market trades in the last 12 months
About Jonathan Slonin's insider trades
Jonathan Slonin is Chief Medical Officer at Pacira BioSciences (PCRX). Since Jun 6, 2022, Jonathan has reported no open-market purchases and 9 sales worth $483K on SEC Form 4. In the last 12 months: 1 sale ($95K).
2 sales (49% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (8 filings), grants and awards (6 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.